Tubingen / Vancouver / Doylestown / Seattle / San Diego / Burnaby / /
Company
F. Hoffman-La Roche Ltd / Monsanto Company / Toronto Stock Exchange / TEKMIRA PHARMACEUTICALS CORP / K. 2 TEKMIRA PHARMACEUTICALS CORPORATION / Hoffman La-Roche Inc. / Inex Pharmaceuticals Corporation / Merck / Indicate / Alnylam Pharmaceuticals Inc. / The NASDAQ Stock Market LLC Securities / Hana Biosciences / Spectrum Pharmaceuticals Inc. / Enantigen Therapeutics Inc. / EDGAR Online Inc. / Protiva Biotherapeutics Inc. / OnCore Biopharma Inc. / /
Country
Canada / Germany / Guinea / United States / /
Currency
USD / /
Event
FDA Phase / Reorganization / General or Shareholder Meeting / M&A / Business Partnership / Funding / Company Expansion / Patent Filing / /
Facility
University of British Columbia / The Baruch S. Blumberg Institute / HBV pipeline / /
IndustryTerm
treatment of human diseases / owned subsidiary / lipid technology / HBV therapies / gene-products / adopted delivery technology / filed several patent applications / treatment of cancer / HBV treatment / manufacturing / biotechnology / lipid nanoparticle delivery technology / delivery technology / liposomal chemotherapy products / corporate Web site / pharmaceutical / biopharmaceutical / pharmaceutical partners / lipid delivery technologies / therapeutic products / focused on developing lipid delivery technologies / /
MedicalCondition
chronic human hepatitis B / viral infection / HBV / alcohol use disorder / cirrhosis / Hepatitis B / human diseases / metabolic disorders / cancer / tumors / hepatocellular carcinoma / diseases / adrenocortical carcinoma / specific disease / infection / infectious disease / significant liver disease / common serious liver infection / cancerous tumors / liver failure / gastrointestinal neuroendocrine tumors / disease / hypertriglyceridemia / serious human diseases / liver cancers / Pipeline Hepatitis B / liver cancer / inflammation / virus disease / chronic Hepatitis B / /
MedicalTreatment
chemotherapy / /
Organization
World Health Organization / UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington / D.C. / Oligonucleotide Therapeutics Society / FDA / Securities and Exchange Commission / Baruch S. Blumberg Institute / HBV / I.R.S. / University of British Columbia / /
Person
Keith Manchester / Patrick T. Higgins / Richard Henriques / Bruce Cousins / Mark J. Murray / Vivek Ramaswamy / Frank Karbe / Michael J. Abrams / Michael J. Sofia / Herbert Conrad / William T. Symonds / / /
Position
head / Chief Scientific Officer / Director Independence / Executive / President and Chief Executive Officer / Chief Discovery Officer / Chief Financial Officer / Principal Accountant / messenger / Chief Development Officer / Chief Operating Officer / leader / Chairman of the Board / /
TEKMIRA PHARMACEUTICALS CORP FORM 10-K (Annual Report)